3 unknown, 2 completed, 1 recruiting, 1 withdrawn. 3 Not applicable, 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 1, Unknown 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Bladder, Overactive: new trials by email Literature Review of Bladder, Overactive trials Research Report on Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome Low-Energy Extracorporeal Shock Wave Therapy (LiESWT), Sham Shock Wave Therapy - Bladder, Lower Urinary Track Symptoms | Not applicable | Recruiting | KMUHIRB-F(I)-20230051 | 60 | 2025-02-10 | 2026-05-04 |
| Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women vaginal 17 beta-estradiol, Placebo, Behavioral modifications - Lower Urinary Tract Symptoms, Female Genitourinary Disease | Phase 4 | Completed | Mahidol University | 86 | 2024-04-08 | 2025-04-20 |
| Laser Treatment of Genito-urinary Syndrome in Women Vaginal laser treatment, sham, laser system - Laser-Induced Scar, Breast Cancer | Not applicable | Withdrawn | Herning Hospital | 2022-10-01 | 2024-10-16 | |
| Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease Medical Cannabis - Bladder, Overactive, Parkinson Disease | Unknown | Sheba Medical Center | 100 | 2021-09-02 | 2021-11-03 | |
| Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB Genital Nerve Stimulation - Bladder, Overactive | Not applicable | Unknown | Prof. Dr. med. Marc Possover | 10 | 2020-01-01 | 2019-11-13 |
| Evaluation of Professional Practices in the Treatment of Refractory Idiopathic Overactive Bladder at the Dose of 50 Units (TOX50IUU) OnabotulinumtoxinA / Botox®, Allergan Ltd, Irvine, CA, United-States - Bladder, Overactive | Unknown | University Hospital, Clermont-Ferrand | 60 | 2019-06-26 | 2019-09-04 | |
| Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder Transvaginal botulinum toxin A (BTA) injection - Overactive Bladder, Bladder, Overactive | Early Phase 1 | Completed | Stanford University | 15 | 2019-06-20 | 2022-07-19 |
Urinary Bladder, Overactive (7) · Nocturia (2) · Urinary Incontinence, Urge (2) · Breast Neoplasms (1) · Endometrial Neoplasms (1) · Female Urogenital Diseases (1) · Lower Urinary Tract Symptoms (1) · Metabolic Syndrome (1) · Pain (1) · Parkinson Disease (1) · Urinary Incontinence, Stress (1) · Vaginitis (1)
Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Urinary Bladder Diseases (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Urological Manifestations (7) · Female Urogenital Diseases (6) · Lower Urinary Tract Symptoms (6) · Urinary Incontinence (2) · Urination Disorders (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Breast Diseases (1)
Botulinum Toxins, Type A (1) · Estradiol (1) · Injections (1) · Medical Marijuana (1) · stearic acid (1)
Herning Hospital (1) · KMUHIRB-F(I)-20230051 (1) · Mahidol University (1) · Prof. Dr. med. Marc Possover (1) · Sheba Medical Center (1) · Stanford University (1) · University Hospital, Clermont-Ferrand (1)
Denmark (1) · France (1) · Israel (1) · Switzerland (1) · Taiwan (1) · Thailand (1) · United States (1)
Amy D. Dobberfuhl, M.D. (1) · Finn F Lauszus (1) · Marc Possover, PhD, MD (1) · Pornthip Harncharoenkul, MD (1) · Saar Anis, MD (1) · Sine Jakobsen, MD, PhD (1) · Yung-Chin Lee, MD,PHD (1)
PMID 21788054, PMID 22865209, PMID 34156506, PMID 35607890, PMID 40709601